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Abstract The skin shows an important “epidermal
permeability barrier homeostasis” in response to bar-
rier disruption. Calcium ion (Ca2+), a major regulator
in keratinocyte diVerentiation and proliferation, plays
a crucial role in skin barrier homeostasis. Acute barrier
disruption induces an immediate depletion of both
extra- and intracellular calcium ions in the epidermis,
especially in the upper granular layers, and results in
the loss of normal epidermal calcium gradient. Cur-
rently, we hypothesize that the change in the intracel-
lular calcium ion concentration triggers the barrier
repair responses, such as lamellar body (LB) secretion
and increased lipid synthesis in the epidermis. In this
article, we suggest that PKC-delta is a signaling media-
tor for the changes in extracellular and intracellular
calcium ion concentration.
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Abbreviations
PKC Protein kinase C
[Ca2+]I Intracellular free calcium concentration
[Ca2+]o Extracellular free calcium concentration
SG Stratum granulosum




Homeostasis is a fundamental process by which living
organisms stably maintain their internal conditions
against external environmental changes. To maintain
homeostasis, our bodies conduct multiple dynamic
equilibrium adjustments, tightly controlled by closely
interrelated regulatory mechanisms. Most of the
homeostatic systems working in our body are com-
prised of three components: receptors, signal transduc-
ers and eVectors (Fig. 1a). The Wrst components,
receptors, sense and report changes in the external
environment. The second components, signal transduc-
ers, convert and magnify the receptor’s signals into
another transducer and/or eVector. This process,
referred to as ‘signal transduction’, generally involves a
sequence of biochemical reactions inside the cell,
which are carried out by enzymes or linked through
second messengers. The last one is the eVectors, which
show the ‘responses’ by eliciting the appropriate cellu-
lar changes in response to the environmental changes.
Most viable organs have homeostatic control sys-
tems. For example, the pancreas produces insulin and
glucagon to control blood-sugar concentration. The
lungs take in oxygen and give oV carbon dioxide. The
kidneys remove urea, and adjust the concentrations of
water and a wide variety of ions.
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54 Arch Dermatol Res (2007) 299:53–57The skin is the largest and the outermost organ of
the human body. Skin controls transcutaneous water
movement, protects the internal organs form mechani-
cal insults, and defends the human body from patho-
genic microbes, UV-irradiation and free radicals. Of
course, the skin also has homeostatic control system; so
called ‘barrier repair response’ (Fig. 1b). When the
barrier is compromised by either external insult or
abnormal nutritional supplement, such as seen in the
essential fatty acid deWciency (EFAD) model, the
homeostatic response includes increasing lamellar
body (LB) secretion and epidermal lipid synthesis [18].
The initiation of the epidermal barrier repair
response depends on a certain signal and several sig-
nals have been suggested as possible candidates.
Firstly, increased transepidermal water loss (TEWL)
and subsequent changes in osmotic pressure of epider-
mal keratinocyte were suggested as regulatory signals
for barrier homeostasis. A series of experiments using
animal models, however, showed that, when the bar-
rier-perturbed skin was immersed in aqueous solution,
the tonicity of the solution did not aVect the barrier
recovery rate, which suggests that the change of tonic-
ity is not a primary signal for barrier homeostasis [15].
Increased secretion and synthesis of epidermal cyto-
kines, subsequent to barrier abrogation, was also
observed in both human and murine skin [31]. The
cytokines are one of the most characterized classes of
signaling molecules and they regulate downstream pro-
cesses of barrier homeostasis, such as keratinocyte pro-
liferation and lipid synthesis [9]. However, the
blockade of permeability barrier recovery using a
water vapor impermeable membrane did not prevent
the change of epidermal cytokine expression, suggest-
ing that the cytokines are not primary signaling mole-
cules for barrier homeostasis.
Ca2+ acts as a major regulator in keratinocyte diVer-
entiation and proliferation and is thought to be a main
signal transducer for skin barrier homeostasis. The con-
centration gradient of Ca2+ within the epidermis, with
its highest levels in the stratum granulosum (SG) and
lowest levels in the basal cell layer [23], is important for
both permeability barrier homeostasis and epidermal
diVerentiation. Barrier disruption causes an immediate
depletion of both intracellular and extracellular calcium
ions in the SG, resulting in the loss of the normal epi-
dermal calcium gradient [20, 22, 24]. Previously, Mauro
et al. [22] showed that the peak Ca2+ concentrations
within the outer epidermis fell from 460 § 57 mg per kg
to 128 § 14 mg per kg immediately after barrier disrup-
tion. Along with the permeability barrier recovery, the
calcium ion concentration in the SG also increased and
immersion of the barrier-perturbed skin into a calcium
ion-containing solution delayed barrier recovery, sug-
gesting a role for calcium ions in epidermal permeabil-
ity barrier homeostasis. The crucial role of Ca2+ in
barrier homeostasis was also shown by the observation
that LB secretion can be manipulated by changes in
Ca2+ by iontophoresis and sonophoresis, independent
of barrier abrogation. These studies suggest that
changes of epidermal calcium can be an important sig-
nal transducer for barrier repair in vivo, independent of
changes in barrier function [17].
However, most of the above studies mention the
role of calcium ions in cutaneous barrier functions as
extracellular calcium gradient or intracellular free cal-
cium level ([Ca2+]i), separately. While the decrease of
extracellular calcium ion concentration after barrier
disruption can be explained by the passive outward cal-
cium ion displacement induced by increased transcuta-
neous water loss, the exact mechanism underlying the
decrease in [Ca2+]i in response to lowered extracellular
calcium ion concentration is still not clear.
There is a substantial and precisely controlled
diVerence between intracellular free calcium ions and
extracellular calcium ion concentration, and the extra-
cellular free calcium level ([Ca2+]o) is usually much
higher than [Ca2+]i [21]. Several diVerent mechanisms
are involved in regulating physiological [Ca2+]i, such as
plasma membrane Ca2+ channels, plasma membrane
calcium ATPase (PMCA), sarco-endoplasmic mem-
brane calcium ATPase (SERCA), and Na+-H+
exchangers (NHEs). Calcium ions, localized intracellu-
larly, are stored within organelles, usually the endo-
plasmic reticulum (sarcoplasmic reticulum in muscle
cells), where it is bound to molecules like calreticulin.
Due to the above mentioned mechanisms, the concen-
tration of free Ca2+ within the cell is usually very low.
Fig. 1 a Three components of 
the homeostatic control sys-
tem: the receptors, the signal 
transducers and the eVectors, 
b barrier repair response and 
c calcium control system in 
keratinocytes123
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ions as a trigger for terminal diVerentiation takes place
and a higher [Ca2+]i than that of the lower SG layers is
observed.
The mechanism of increased [Ca2+]i in the upper SG
layer in response to the elevation of extracellular cal-
cium is understood by degrees [28]. Previous studies [2,
10, 30] suggested that the extracellular calcium-sensing
receptor (CaR) is involved in mediating calcium signal-
ing during keratinocyte diVerentiation. Activation of
CaR with calcium or other multivalent cations acti-
vates the phospholipase C signaling pathway, resulting
in the generation of inositol 1, 4, 5-trisphosphate, the
release of calcium from intracellular stores [4, 14] and a
subsequent increase in calcium inXux through nonspe-
ciWc cation channels and a storage-operated calcium
channel. This is followed by the activation of PKC [18]
and elevated expression of diVerentiation-related
genes such as loricrin, proWlaggrin, and transglutamin-
ase [5]. During the diVerentiation process of keratino-
cytes, PKC activation not only precedes the expression
of diVerentiation markers but also induces diVerentia-
tion [5, 6, 8, 17]. And the speciWc PKC isotype, PKC,
has been implicated in this process [5, 6, 16].
We hypothesized that the decrease of [Ca2+]i might
be mediated by some signal transducers during the
acute barrier disruption, just as the increase of [Ca2+]i
is mediated by receptors and signal transducers (such
as CaR, phospholipase C and PKC) during terminal
diVerentiation. Murata et al. demonstrated that both
serine-palmitoyl transferase and glucosylceramide syn-
thetase expression were increased through a PKC-
dependent mechanism in cultured human keratino-
cytes.1 This result provides a hint that PKC may be a
key candidate signal transducer for the decrease of
[Ca2+]i. So, we investigated the eVects of PKC inhibi-
tors on the barrier recovery [1]. Our results show that
both a broad-type PKC inhibitor and a speciWc PKC
inhibitor reduced barrier recovery (Fig. 2), speciWcally
through the inhibition of the [Ca2+]i decrease by PKC
(especially PKC) (Fig. 3). While both a broad-type
PKC inhibitor and a speciWc PKC inhibitor showed
the inhibitory eVect on the decrease of [Ca2+]i after
lowering [Ca2+]o,as shown in Figs. 3b, c, the intracellu-
lar calcium responses to chelerythrine chloride (broad-
type PKC inhibitor) is slightly diVerent from that of
rottlerin (speciWc PKC inhibitor). The calcium trace
of chelerythrine chloride-treated keratinocytes showed
an unstable and increasing baseline. And when the
extracellular calcium level was increased, the increase
of calcium trace of chelerythrine chloride was slower
than that of rottlerin. Because this type of calcium
trace can be shown for unregulated calcium inXux such
as with the cytotoxic eVect, we measured the cytotoxic-
ity of chelerythrine chloride and rottlerin in cultured
keratinocytes by the Alamar Blue™ assay. This study
showed less than ten percent cytotoxicity in the chel-
erythrine chloride-treated cell culture. But rottlerin
didn’t show any cytotoxicity at all. Although, the cal-
cium trace of chelerythrine chloride showed an increas-
ing baseline and slower increase, we think these
features are secondary eVects due to weak cytotoxicity
which masks the typical calcium curve as shown in
Fig. 3c. Also, because chelerythrine chloride is a broad-
type PKC inhibitor, its eVect could be the sum of other
blocking eVects from other isoenzymes of PKC other
than delta.
The role of PKC in keratinocyte diVerentiation is
well known, but until now, nothing was known about
its role in the barrier recovery response, especially with
regards to the decrease of [Ca2+]i. But, a similar regula-
tion of [Ca2+]i is seen in cells other than keratinocytes,
namely granulosa cells. Basic Wbroblast growth factor
1 S Murata, Y. Uchida, S. Ichikawa, Y Hirabayashi, W.M. Holler-
an: Regulation of Glucosylceramide synthase expression in cul-
tured Human Keratinocytes. J Invest Dermatol 114: 795, 2000
(abstr.).
Fig. 2 Broad-type PKC inhibitors and speciWc PKC inhibitor
delay the barrier recovery. a Topical application of chelerythrine
chloride, a broad-type PKC inhibitor, delayed the barrier recov-
ery rate in a dose-dependent manner. b The percent recovery of
TEWL in rottlerin-treated skin was also decreased in a dose-
dependent manner (**P < 0.01)123
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[19]. Peluso et al. [25] elucidated the mechanism
through which bFGF-activated PKC regulates [Ca2+]i
within a physiological range by stimulating calcium
eZux. They proposed that activated PKC functions as
a serine/threonine phosphorylator of various molecular
targets that may include calcium eZux regulators, such
as PMCA. As shown in other cell types, TPA-depen-
dent phosphorylation of PMCA enhances the rate of
calcium eZux, thereby maintaining calcium homeosta-
sis [13]. The PMCA pumps are localized in the plasma
membrane, and their activities are inXuenced by PKC
[3, 26, 29]. But, PKC is the only PKC isotype that is
expressed by granulosa cells. The existence of PKC, ,
,  and  in keratinocytes is well-documented [5, 7, 11,
17] and other PKC isoforms (namely PKC, , and )
were also found in various keratinocyte cell lines [11,
12, 27]. Among the normally existing PKC isoenzymes
in keratinocytes, PKC is a novel isoform of PKC, and
is DAG-sensitive but calcium-insensitive. These results
suggest the role of PKC- as a signal mediator in epi-
dermal permeability barrier homeostasis, especially in
regulating intracellular calcium concentration.
Our suggested mechanism of calcium regulation by
PKC is shown in Fig. 4. When the permeability barrier
is disrupted, there is TEWL increase, followed by a
decrease of the extracellular calcium level in the upper
epidermis. The extracellular calcium loss is sensed and
reported by an unknown receptor. This receptor may
increase the level of DAG, an endogenous PKC activa-
tor, and activate PKC as a signal transducer. And this
signal may regulate the decrease of [Ca2+]i by stimulat-
ing calcium eZux through activation of an exchange
channel or pump like PMCA. And then, the decrease
of [Ca2+]i induces a variety of responses for barrier
repair such as LB secretion. However, in our proposed
homeostatic barrier control mechanism, there are miss-
ing links between the decrease of [Ca2+]o and the
decrease of [Ca2+]i (Fig. 1c). As mentioned before, dur-
ing keratinocyte diVerentiation, CaR senses the
increase of [Ca2+]o and nonspeciWc cation channels and
storage- operating calcium channels increase [Ca2+]I.
As in keratinocyte diVerentiation, there may be a
receptor for sensing the decrease of [Ca2+]o and an
eVector for decreasing [Ca2+]i. Future studies are nec-
essary to test this hypothesis and to Wnd the receptor
and eVector. Previously, we have reported several tech-
niques to induce LB secretion without permeability
barrier abrogation. Currently, using similar methods,
eVects of selective modulation of epidermal calcium
gradient on PKC- activation is under investigation.
And these investigations may provide additional evi-
dences for the role of PKC- as a signaling mediator in
epidermal permeability barrier homeostasis.
Fig. 3 Broad-type and delta-speciWc PKC inhibitors impede the
decrease of [Ca2+]i. a The increase [Ca2+]o from 0.15 (HEPES-
buVered low Ca2+ solution) to 1.5 mM (HEPES-buVered high
Ca2+ solution) induced an increase of [Ca2+]i. And elevated
[Ca2+]i returned to the baseline level after lowering [Ca2+]o to
0.15 mM. b In the case of chelerythrine chloride-treated (5 M)
keratinocytes, there was a slight increase in [Ca2+]i at baseline.
The increase of [Ca2+]o from 0.15 to 1.5 mM induced an increase
in [Ca2+]i and the elevated [Ca2+]i did not return to the baseline
level after lowering [Ca2+]o to 0.15 mM. c In rottlerin-treated
(10 M) keratinocytes, [Ca2+]i also did not return to the baseline
and maintained the elevated [Ca2+]i even after lowering [Ca2+]o
to 0.15 mM. The data in this graph represent the mean of ten cells
Fig. 4 Our model for the mechanism of intracellular calcium reg-
ulation by PKC123
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